Drug
Propiverine Hydrochloride
Propiverine Hydrochloride is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
1
20%
Ph not_applicable
2
40%
Ph phase_2
1
20%
Ph phase_4
1
20%
Phase Distribution
0
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
2(40.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (20.0%)
Phase 31 (20.0%)
Phase 41 (20.0%)
N/A2 (40.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completednot_applicable
Effect of Interferential Electrical Stimulation on Pain Perception and Disability Level on Interstitial Cystitis
NCT03844581
completednot_applicable
Female Patients With Signs of uRgE and Stress Urinary Incontinence Study of Propiverine Hydrochloride
NCT01942681
completedphase_3
Propiverine Hydrochloride Extended-Release Capsule for Overactive Bladder
NCT01512004
completedphase_4
Urinary Urgency Outcomes Following Propiverine Treatment for an Overactive Bladder
NCT00903045
completedphase_2
Dose-Escalating Study of Propiverine Hydrochloride in Children Suffering From Overactive Bladder
NCT00795925
Clinical Trials (5)
Showing 5 of 5 trials
NCT03844581Not Applicable
Effect of Interferential Electrical Stimulation on Pain Perception and Disability Level on Interstitial Cystitis
NCT01942681Not Applicable
Female Patients With Signs of uRgE and Stress Urinary Incontinence Study of Propiverine Hydrochloride
NCT01512004Phase 3
Propiverine Hydrochloride Extended-Release Capsule for Overactive Bladder
NCT00903045Phase 4
Urinary Urgency Outcomes Following Propiverine Treatment for an Overactive Bladder
NCT00795925Phase 2
Dose-Escalating Study of Propiverine Hydrochloride in Children Suffering From Overactive Bladder
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5